Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Clinical and Vaccine Immunology : CVI|January 7, 2011
The chimeric protein domain III-capsid of dengue virus serotype 2 (DEN-2) successfully boosts neutralizing antibodies generated in monkeys upon infection with DEN-2Iris Valdés, Lázaro Gil, Yaremis Romero, et al.
Archives of Virology|May 21, 2014
A tetravalent dengue vaccine containing a mix of domain III-P64k and domain III-capsid proteins induces a protective response in miceAlienys Izquierdo, Angélica García, Laura Lazo, et al.
Biotechnology and Applied Biochemistry|July 19, 2008
Dengue-4 envelope domain III fused twice within the meningococcal P64k protein carrier induces partial protection in miceLaura Lazo, Aída Zulueta, Lisset Hermida, et al.
Biochemical and Biophysical Research Communications|August 14, 2003
The fusion site of envelope fragments from each serotype of Dengue virus in the P64k protein, influence some parameters of the resulting chimeric constructsAída Zulueta, Lisset Hermida, Laura Lazo, et al.
The Journal of General Virology|March 9, 2012
Recombinant nucleocapsid-like particles from dengue-2 induce functional serotype-specific cell-mediated immunity in miceLázaro Gil, Lídice Bernardo, Alequis Pavón, et al.
Microbiology and Immunology|April 3, 2014
Evaluation in mice of the immunogenicity and protective efficacy of a tetravalent subunit vaccine candidate against dengue virusLaura Lazo, Alienys Izquierdo, Edith Suzarte, et al.
Virology|June 4, 2014
Capsid protein: evidences about the partial protective role of neutralizing antibody-independent immunity against dengue in monkeysLázaro Gil, Alienys Izquierdo, Laura Lazo, et al.
Archives of Virology|April 11, 2017
A dose-response study in mice of a tetravalent vaccine candidate composed of domain III-capsid proteins from dengue virusesIris Valdés, Ernesto Marcos, Edith Suzarte, et al.
Vaccine|August 20, 2023
Recombinant protein based on domain III and capsid regions of zika virus induces humoral and cellular immune response in immunocompetent BALB/c miceIris Valdes, Lázaro Gil, Laura Lazo, et al.
Vaccine|August 13, 2024
Addition of nucleotide adjuvants enhances the immunogenicity of a recombinant subunit vaccine against the Zika virus in BALB/c miceIris Valdes, Edith Suzarte, Laura Lazo, et al.
Pageof 5